| Literature DB >> 29456789 |
Abstract
Although vancomycin has been in clinical use since the late 1950s, resistance due to alteration in the target microbe's peptidoglycan can vary significantly, reducing its activity. Total synthesis of derivatives has now led to a molecule with very significant activity against resistant strains.Entities:
Year: 2018 PMID: 29456789 PMCID: PMC5807861 DOI: 10.1021/acsmedchemlett.8b00029
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345